skip to content
Systematic Reviews of Treatments for Complications of Diabetes
Follow the links below to find summaries of systematic reviews of evidence for the effectiveness of treatments for complications of diabetes, and about complications associated with diabetes treatments.
Reviewed January 2012
16 Resources Found
Results 1 to 16 displayed.
| Title: | Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Patients with type 2 diabetes mellitus (T2D) have an elevated mortality and morbidity compared to the general population. T2D is characterised by several metabolic defects that include impaired insulin secretion and action causing chronic hyperglycaemia... |
| Date: | Dec 2010 |
| Title: | Prostaglandin E1 for preventing the progression of diabetic kidney disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Continuous albuminuria (protein in the urine) is the major characteristic of diabetic kidney disease (DKD), which is regarded primary cause of death and poor health in patients with diabetes mellitus, leading to end-stage-kidney disease. While blood pre... |
| Date: | Feb 2010 |
| Title: | Does altering dietary salt intake aid in the prevention and treatment of diabetic kidney disease? |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | There is strong evidence that our current consumption of salt is a major factor in increasing blood pressure (BP), whether BP levels are normal or raised. Diabetes makes it more likely to develop high BP, which increases the risk of strokes, heart attac... |
| Date: | Jan 2010 |
| Title: | There is currently no evidence of effects of heparin and related substances for preventing the onset of diabetic kidney disease (DKD) |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Heparin and related substances, including glycosaminoglycans, chondroitin, low-molecular-weight heparin (LMWH), heparinoids, heparitin sulfate, hyaluronic acid and keratan sulphate, have been demonstrated a few positive effects on delaying the progressi... |
| Date: | Oct 2009 |
| Title: | Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Metformin, a medication used to lower glucose levels in patients with diabetes mellitus, has long been thought to increase the risk for a metabolic disorder known as lactic acidosis. This review summarised data from all known comparative and observation... |
| Date: | Oct 2009 |
| Title: | Immunotherapy for diabetic amyotrophy |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Results from trials are awaited to show whether corticosteroids, immunoglobulin or other treatments that act on the immune system are beneficial in diabetic amyotrophy. Diabetic amyotrophy or diabetic lumbosacral radiculoplexus neuropathy is an uncommon... |
| Date: | Apr 2009 |
| Title: | Not enough evidence is available to prove that hormonal contraceptives do not influence glucose and fat metabolism in women with diabetes mellitus. |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | It is important for women with diabetes mellitus type 1 and 2 to receive good advice which contraceptive method is best to use. Unplanned pregnancies can lead to serious health issues for both mother and child in women with diabetes. Yet, hormonal contr... |
| Date: | Dec 2008 |
| Title: | Lower limb surgery to release trapped nerves in diabetic neuropathy |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | This review analyzed the role of decompressive surgery of lower limb nerves for symmetrical diabetic peripheral neuropathy. Peripheral neuropathy is one of the most common complications of diabetes. Pain and numbness in the feet are common features. Pai... |
| Date: | Apr 2008 |
| Title: | Aldose reductase inhibitors for the treatment of diabetic polyneuropathy |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Polyneuropathy is a common complication of diabetes mellitus that causes pain and sensory and motor deficits in the arms and legs. It can also lead to foot ulcers and amputation. Aldose reductase inhibitors are a class of medications that block the brea... |
| Date: | Aug 2007 |
| Title: | Rosiglitazone for type 2 diabetes mellitus |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Diseases of the heart and blood vessels account for approximately 70% of all mortality in people with diabetes. Compared to their non-diabetic counterparts the relative risk of mortality caused by disorders of the heart and blood vessels is two to three... |
| Date: | Apr 2007 |
| Title: | Protein restriction for diabetic renal disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Based on 12 studies, including from eight to 160 people with type 1 and type 2 diabetes for at least an average four-month period, restricted protein intake appeared to slow progression of diabetic kidney disease, but not by much on average. However, in... |
| Date: | May 2006 |
| Title: | Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Erectile dysfunction is a common multi-factorial complication of diabetes mellitus. Newer medications, like the so-called PDE-5 inhibitors result in enhancement of penile erection. The introduction of sildenafil (Viagra), vardenafil (Levitra) and tadala... |
| Date: | Oct 2005 |
| Title: | Angiotensin converting enzyme inhibitors (ACEi) were found to be effective for the primary prevention of kidney disease in patients with diabetes |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Twenty to sixty percent of diabetic patients are affected by hypertension and antihypertensive agents are used to treat this condition. These agents are also used to prevent the onset of kidney disease both in normotensive and hypertensive diabetics. Tw... |
| Date: | Aug 2005 |
| Title: | No evidence that treatment or level of control of Type II diabetes influences cognitive function |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Type II diabetes is a chronic disease characterized by high blood glucose levels. It needs to be treated with diet, oral drugs and sometimes insulin to control symptoms and avoid organ damage. Patients may develop features of cognitive decline (e.g. mem... |
| Date: | Aug 2005 |
| Title: | Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Obesity is closely related to type 2 diabetes and weight reduction is an important part of the care delivered to obese persons with diabetes. This review of drugs for weight loss among adults with type 2 diabetes revealed weight loss of between 2.0 and ... |
| Date: | Jun 2004 |
| Title: | Metformin monotherapy for type 2 diabetes mellitus |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Our review confirm that tight glycaemia control with metformin monotherapy is one of the main therapeutic options for type 2 diabetes in patients with overweight or obesity, since it may prevent some events of macrovascular and microvascular complicatio... |
| Date: | Sep 2003 |
Results 1 to 16 displayed.
